dalteparin has been researched along with Acute Confusional Senile Dementia in 6 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar-Pineda, JA | 1 |
| Paco-Coralla, SG | 1 |
| Febres-Molina, C | 1 |
| Gamero-Begazo, PL | 1 |
| Shrivastava, P | 1 |
| Vera-López, KJ | 1 |
| Davila-Del-Carpio, G | 1 |
| López-C, P | 1 |
| Gómez, B | 1 |
| Lino Cardenas, CL | 1 |
| Assad, M | 1 |
| Coffin-Pichonnet, S | 1 |
| Billotte, C | 1 |
| Denion, É | 1 |
| Cui, H | 1 |
| King, AE | 1 |
| Jacobson, GA | 1 |
| Small, DH | 1 |
| Timmer, NM | 1 |
| van Dijk, L | 1 |
| van der Zee, CE | 1 |
| Kiliaan, A | 1 |
| de Waal, RM | 1 |
| Verbeek, MM | 1 |
| Bergamaschini, L | 1 |
| Rossi, E | 1 |
| Storini, C | 1 |
| Pizzimenti, S | 1 |
| Distaso, M | 1 |
| Perego, C | 1 |
| De Luigi, A | 1 |
| Vergani, C | 1 |
| De Simoni, MG | 1 |
| Wang, P | 1 |
| Ding, K | 1 |
1 review available for dalteparin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Proteoglycans and glycosaminoglycans in misfolded proteins formation in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Clinical Trials as Topic; Glycosaminoglycans; Heparin, Low | 2014 |
5 other studies available for dalteparin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
In Silico Analysis of the Antagonist Effect of Enoxaparin on the ApoE4-Amyloid-Beta (A
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apolipoprotein E3; Apolipoprotein E4; Enoxaparin; | 2022 |
[Acute unilateral arteritic anterior ischemic optic neuropathy becoming bilateral despite corticosteroid therapy].
Topics: Acute Disease; Aged; Alzheimer Disease; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Disease P | 2016 |
Peripheral treatment with enoxaparin exacerbates amyloid plaque pathology in Tg2576 mice.
Topics: ADAM10 Protein; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Pr | 2017 |
Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognition Disorders; Disease Models, Animal; Enox | 2010 |
Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Cerebral Cortex; Complement Activatio | 2004 |